Optic Nerve Injury in Obstructive Sleep Apnea Patients

Ischemic optic neuropathy (ION) is damage to the optic nerve caused by ischemia and hypoxia in the optic nerve due to impairment of the blood supply of the arteries supplying the optic nerve. ION is an important blinding eye disease. It has been found that patients with OSAHS are often misdiagnosed as having normotensive glaucoma due to chronic hypoxia resulting in optic nerve ischemia and hypoxia, leading to the development of ION. However, the correlation between the two has been poorly studied and is uncertain due to the lack of accurate methods to evaluate blood flow.

The study will enroll 80 patients from the First Affiliated Hospital of Nanjing Medical University between the ages of 18-80 years. Participants will be diagnosed with OSA according to established guidelines and must be first-time visitors with no prior history of OSA surgery or CPAP treatment. Patients with severe cerebrovascular disease, psychiatric disorders, diagnosed diabetes mellitus with severe vascular complications, severe COPD, pulmonary hypertension, heart failure, or pregnancy will be excluded.

All participants will undergo a polysomnography (PSG) to determine the Apnea Hypopnea Index (AHI) and will be categorized into mild, moderate, or severe OSA groups. Ophthalmologic-related examinations will be performed to measure ocular parameters such as optic nerve and macular blood flow OCT, visual acuity, refraction, intraocular pressure (IOP), visual fields, and IOLMaster measurements of the eye axis.

Eligible patients will receive CPAP treatment for 3 months. After 3 months of CPAP treatment, participants will undergo another PSG examination with ophthalmologic correlation to re-evaluate sleep parameters and ocular parameters.

The collected data will be analyzed using SPSS software. Correlation analysis will be performed to assess the relationship between AHI, minimum SPO2, hypoxic load, respiratory load, blood pressure variability, heart rate variability, pulse wave amplitude decline index, ESS drowsiness score, and the following ophthalmologic parameters: optic nerve and macular blood flow OCT, visual acuity, refraction, intraocular pressure, visual field, and eye axis as measured by IOLMaster. Paired t-tests will be performed to analyze the changes in the above indexes before and after CPAP treatment; ANOVA with repeated measurements will be performed to analyze the long-term changes in the above indexes.

The aim of this study is to analyze the relationship between sleep apnea severity hypoxia indexes and ION in OSAHS patients. To analyze the improvement of ischemic optic neuropathy (ION) after 3 months of CPAP treatment and to establish a long-term cohort to observe the occurrence of ION in patients with OSA of different severities, as well as the improvement of ION with long-term CPAP treatment.

• Time below 90% Saturation [Срок оценки: Baseline and 3 months of CPAP therapy]
• Lowest SpO2 at night [Срок оценки: Baseline and 3 months of CPAP therapy]
• Mean SpO2 [Срок оценки: Baseline and 3 months of CPAP therapy]
• Oxygen Desaturation Index [Срок оценки: Baseline and 3 months of CPAP therapy]
• Vision [Срок оценки: Baseline and 3 months of CPAP therapy]
• Diopter [Срок оценки: Baseline and 3 months of CPAP therapy]
• Intraocular pressure [Срок оценки: Baseline and 3 months of CPAP therapy]
• Field of view [Срок оценки: Baseline and 3 months of CPAP therapy]
• Axon of the eye [Срок оценки: Baseline and 3 months of CPAP therapy]